With the progression of NASH, metabolic disorders, for example, dyslipidemia, insulin resistance, and glucose intolerance, would collectively advance the renin-angiotensin (RAS) system system and influence nitric oxide formation (70–72), which can facilitate the progression of DN. The gene discussed is REN; the disease is liver dysplastic nodule.